Table 2.
VEGFR-2 immunohistochemical staining of melanoma specimens and demographics of patients positive for VEGFR-2 from 8 TMAs using VEGFR-2 55B11 Antibody
| VEGFR-2 (55B11 Antibody) | Number (%) |
|---|---|
| Positive | 11 (7%) |
| Rare + | 1 |
| Focal + | 2 |
| +/− | 3 |
| + | 5 |
| Negative | 156 (93%) |
|
| |
| Total patient tumor specimens | 167 |
| Demographics of 11 patients with melanomas positive for VEGR-2 | |
|---|---|
| Age (mean±SD) | 55.58±15.68 |
|
| |
| Sex | |
| Male | 5 |
| Female | 6 |
|
| |
| Melanoma Location | |
| Primary | 1 |
| Metastatic | 10 |
| Lymph Node | 4 |
| Skin/Soft Tissue | 5 |
| Small Intestine | 1 |
|
| |
| Histology | |
| Epithelioid | 10 |
| Spindle | 1 |
| Mixed | 0 |